| CTRI Number |
CTRI/2023/05/052294 [Registered on: 04/05/2023] Trial Registered Prospectively |
| Last Modified On: |
23/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Case Control Study |
| Study Design |
Other |
|
Public Title of Study
|
Effect of 18 types of food combination on psoriasis |
|
Scientific Title of Study
|
To study the role of Ashtadasha Viruddha Ahara in the etiopathogenesis of Ekakushtha with special reference to Psoriasis-A case control study |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Aarti Devi |
| Designation |
MD scholar |
| Affiliation |
institute of teaching and research in Ayurveda Jamnagar |
| Address |
Department of rog nidan and vikriti vigyan fifth floor institute building ITRA
Jamnagar GUJARAT 361008 India |
| Phone |
9041287614 |
| Fax |
|
| Email |
bkaartid@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Chinmayi C Shah |
| Designation |
Reader |
| Affiliation |
Institute of teaching and research in Ayurveda Jamnagar |
| Address |
room no 517 fifth floor department of rog nidan and vikriti vigyan institute building ITRA
Jamnagar GUJARAT 361008 India |
| Phone |
9998964805 |
| Fax |
|
| Email |
drcu_16@hotmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Chinmayi C Shah |
| Designation |
Reader |
| Affiliation |
Institute of teaching and research in Ayurveda Jamnagar |
| Address |
room no 517 fifth floor department of rog nidan and vikriti vigyan institute building ITRA
Jamnagar GUJARAT 361008 India |
| Phone |
9998964805 |
| Fax |
|
| Email |
drcu_16@hotmail.com |
|
|
Source of Monetary or Material Support
|
| Institute of Teaching and Research in Ayurveda Jamnagar Gujarat 361008 |
|
|
Primary Sponsor
|
| Name |
Institute of Teaching and Research In Ayurveda Jamnagar Gujarat 361008 |
| Address |
opposite reliance mart ITRA Jamnagar |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Aarti Devi |
ITRA hospital Jamnagar |
OPD No 16 Department of roga nidana and Vikriti vijnana,Institute of Teaching and research in ayurveda hospital, Opp city B division police station,Pn Marg,Jamnagar,Gujarat 361008 Jamnagar GUJARAT |
9041287614
bkaartid@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Age and gender matched healthy individuals who have Annabhilasha, Bhuktasyaparipakasukhena, sukhaswapanprabodhan, prashannendriya, Srishtavitta-mutra-vata, bala-varna smaagnit, shareeralaghava, saumanasya will be selected as control |
| Patients |
(1) ICD-10 Condition: L409||Psoriasis, unspecified, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients of age between 18 yrs. to 60 yrs
Patients willing to participate and follow study protocol
Patients with the chronicity of 2 years
Patients with controlled DM (FBS ≤130mg/dl) and HTN (systolic B.P.-110-140 mm of Hg and diastolic-70-90mm of Hg) and who follow regular medication for the same
|
|
| ExclusionCriteria |
| Details |
Patients of age < 18 yrs. & >60 yrs. of age
Patients not willing to abide by study protocol
Patients with the chronicity of >2 years
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the exposure of eighteen types of Viruddha Ahara in ekakushtha and psoriasis patients |
0ne day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Nil |
Nil |
|
|
Target Sample Size
|
Total Sample Size="200" Sample Size from India="200"
Final Enrollment numbers achieved (Total)= "96"
Final Enrollment numbers achieved (India)="96" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
08/05/2023 |
| Date of Study Completion (India) |
15/09/2024 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
15/09/2024 |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
not yet published |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
Present work is a case control study for which 48 subjects had been recruited in each group to assess the Ashtadsha Viruddha Ahara in the context of Ekakushtha. In case group, patients of Ekakushtha diagnosed according to presence of general symptoms of Ekakushtha like Aswedanam (absence of sweat), Mahavastu (which covers large area) and Matsyashakalawat twacha (skin resembles scales of fish) are considered along with the current gold standard for assessment of extensive psoriasis i.e. Psoriasis Area and Severity Index (PASI) between the age of 18 yrs to 60 yrs. and chronicity 2 yr. were enrolled. Whereas in control group age and gender matched healthy individuals were selected. A closed ended questionnaire containing demographic details, Ashthadasha Viruddha Ahara on the basis of classics and present times with relevant examinations was prepared and used for data collection. In both group hemoglobin, complete blood count, fasting blood sugar, lipid profile, renal profile, were carried out to rule out any other pathology condition. Obtained data from survey of case and control groups had been presented in tabular form and statistical tests such as chi square, odds ratio and confidence interval (CI) were applied and interpreted. In this study, maximum participants observed were of age group 51-60 yrs. (case and control- 29.16 each), male (case and control-52.1% each), Hindu (case-91.67%, control- 93.75%), married (case-77.1%, control- 83.33%), urban resident (case- 56.3%, control- 45.83%), Jangala Desha (case- 97.6%, control- 83.33%), graduate (case- 37.5%, control- 47.91%), housewife (case- 37.09%, control-32.25%) and middle class (case- 64.6% , control-75% and 80.64% respectively). on comparing the data from case and control group both (OR and chi square are highly significant for Paka Viruddha Ahara (OR – 9.0 chi square 20.3) Matra Viruddha Ahara (OR 10.52 chi square 26.3) Vidhi Viruddha Ahara ( OR 11.4 , chi square 28.2 ) Desha Viruddha Ahara ( OR 18.8, chi square 35.8 ) Kostha Viruddha Ahara ( OR 21, chi square 38.09) significant for Samyoga Viruddha Ahara ( OR 3.7, chi square 9.5 ) Kala Viruddha Ahara (OR 2.6, chi square 5.15 ) Parihara Viruddha Ahara ( OR 10.4 ,chi square 12.0 ) Upchara Viruddha Ahara ( OR 20.35 chi square 8.72) Virya Viruddha Ahara ( OR 4.1 chi square 8.7 ) Krama Viruddha Ahara ( OR 10.12, chi square 8.7 ) Samskara Viruddha Ahara ( OR 10.12 ,chi square 15.03) Sampada Viruddha Ahara ( OR 47, chi square 28.61 ) Hridya Viruddha Ahara ( OR 28.20 ,chi square 18.96 ) Agni Viruddha Ahara ( OR 3.66, chi square 4.8 ) Dosha Viruddha Ahara ( OR 7.27 chi square 14.89 ) insignificant for Satmya Viruddha Ahara ( OR 0.31, chi square 1.04 ) Avastha Viruddha Ahara (OR 1.69 chi square 1.56 ). It shows that Ashtadasha Viruddha Ahara play significant role for manifestation of diseases. Thus, we can conclude null hypothesis is rejected and alternate hypothesis i.e., there is a positive role of Ashtadasha Viruddha Ahara in the etipathogenesis of Ekakushtha with special reference to Psoriasis is accepted. |